Richard Tanner

Consultant Cardiologist, Cork University Hospital, and Mater Private Hospital

[Richard Tanner @RichCardioMD]

https://t.co/Gde1da6AgO

[Richard Tanner @RichCardioMD]

Residual inflammatory & cholesterol risk after PCI
- 15,494 patients on statin tx
- 40% with elevated hsCRP
- hsCRP >2mg/L independently associated with MACE @ 1 yr
- LDL >70mg/dL not associated with MACE @ 1 yr
- Difference in MACE driven by all-cause mortality & spontaneous MI

[EuroIntervention @EuroInterventio]

In this editorial, Prof. Sabaté comments on 3-year outcomes from Tanner et al. on intracoronary brachytherapy for multilayer DES ISR. Despite limitations, the data reintroduce a technique once considered obsolete.
https://t.co/YuImU3JDBX

[Richard Tanner @RichCardioMD]

@MountSinaiHeart @EuroInterventio

[Richard Tanner @RichCardioMD]

Does intravascular brachytherapy (IVBT) still have a role in treating in-stent restenosis (ISR)?
Multilayer ISR may be a niche indication for this metal free strategy

[Irish Association of Cardiac Rehabilitation (IACR) @IRehabilitation]

➡️The considerable psychological impact of heart disease on patients and their families. 🧠👇

[Richard Tanner @RichCardioMD]

Structural Heart Disease fellowship @MountSinaiHeart complete! Excellent teaching & hands-on experience with MitraClip & TriClip. My sincere thanks to the entire Structural Heart team! @DoctorKini @GilbertTangMD @ParasuramMD @KHERA_MD @LucySafi @georgedangas @SaminSharmaMD

[Dr. Gilbert Tang @GilbertTangMD]

👏🏼🎉New class of @MountSinaiHeart trained structural ❤️interventionalists + imagers. Ready to help pts from around the 🌎! Super proud! @sratanapo @RichCardioMD @RSamtaniMD @PassanitiGiulia @prandi_fr @NanaToyodaMD @DoctorKini @KHERA_MD @ParasuramMD @LucySafi @georgedangas

[JAHA @JAHA_AHA]

With shared decision-making, patients sometimes prefer PCI over the recommended CABG. @DrAnoop_Koshy @GreggWStone @DoctorKini and colleagues investigate the outcomes of such decisions in complex coronary cases. #AHAJournals @MountSinaiHeart https://t.co/EKfHXDiFFc

[Justin Sharim MD @JSharimMD]

Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the AHA

Risk stratified by drug class 👇

[Richard Tanner @RichCardioMD]

Delighted to contribute to an expert panel discussion on the lifetime management of aortic stenosis this morning at #NYValves2024

[Cardiovascular Research Foundation @crfheart]

🫀A distinguished panel of experts examine bioprosthetic valve durability and the lifetime management of #aorticstenosis at this morning’s FDA Town Hall session. 🩺 #NYValves2024

#CardioX #CardioTwitter #CardioEd #CardioResearch

@TheDoctorMack @aakriti_15 @drroxmehran @MJReardon1 @SammyElmariahMD

[Gregg W. Stone MD @GreggWStone]

Novel publ in JAHA from our group at Mt Sinai. 3687 pts with MVD and SS >22. Documents for the first time (to my knowledge) worse outcomes (including death) after PCI in pts eligible and recommended for CABG who refused, even after adjustment for SS and other covariates.

[CCC Live Cases @ccclivecases]

Watch First LIVE Case in the World of TF-TAVR with the Novel 26mm Evolut FX+ - Tomorrow at 9am EDT
https://t.co/lLZG6WvdPN

#cardiotwitter #cardiox #cardiology #structuralheart #TAVR #SAVR

[Lucy @LucySafi]

Grand rounds @MountSinaiHeart with expert panelists Dr. Fuster, Dr Bhatt, Dr Adams, Dr Kini, Dr Lerakis moderated by Dr Stone discussing MV disease.

Doesn’t really get better than that!

@DLBHATTMD @DoctorKini @GreggWStone

[Dr. Gilbert Tang @GilbertTangMD]

Proud to be @MountSinaiHeart ❤️team FIRST commercial #TriClip G4 T-TEER to Rx primary TR & #2 overall in US. Large anterior prolapse Quadricuspid TV: 5➡️1+ TR w/ 1 XTW. ⬆️RV flow, BP, ⬇️RAP. Only commissural jet left. No pacer, no AC needed home next day. Big win for our pts!

[Richard Tanner @RichCardioMD]

Out now in @JACCJournals, our analysis on the role of inflammation in risk prediction among HBR patients undergoing PCI, led by @manishvinayak
👉 ⬆️ hsCRP is associated with high ischemic but not bleeding events
👉 measuring hsCRP may help guide antiplatelet tx in HBR patients

[Richard Tanner @RichCardioMD]

@leoneppmd @azeemlatib @duanepinto @georgedangas @HeartOTXHeartMD @SebLudwig1 @Ortega_Paz @OhnoTuri @crfheart @SVRaoMD @rwyeh @RadialFirstBot @Drroxmehran @mauro_gitto @AngeloOliva3 @GreggWStone Great work Pier!

[Dr. Gilbert Tang @GilbertTangMD]

Amazing redo #TAVR live case #SHA2024 @MBalghith @ccclivecases @MountSinaiNYC @MountSinaiHeart @IcahnMountSinai by @DoctorKini @KHERA_MD & our ❤️team of 23S3U Resilia in 29 Evolut for severe PVL. 👏🏼 @bapat_savrtavr @Miho_Fukui_ for the analysis! @LucySafi @Asaadakbarkhan

[Dr. Gilbert Tang @GilbertTangMD]

Huge milestone @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai as we 📈>💯 #MitraClips #Mitral #TEER in 2023. Congrats our A++ ❤️team of structural ❤️cardiologists, surgeons & imagers! @DoctorKini @DrSaminKSharma @DrDavidHAdams @DrStamLerakis @LucySafi @KHERA_MD @ParasuramMD

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Great #AHA23 so far: @AHA_Research

🥸8 Trials: 8 take aways below

Read the read👇👇

1/ATRESIA:

Patients with subclinical atrial fibrillation can benefit from apixaban to reduce the risk of stroke and systemic thromboembolism.